The current weakness in Singapore’s exports is likely to extend into the first half of 2021, following a weakening of global demand over the same period says RHB’s Singapore research team in a report dated Dec 21.

However, the team also sees that exports from the pharmaceutical sector could remain “resilient” based on its in-house assumption of a gradual global roll-out of the Covid-19 vaccine in 2021, says the team.


For more stories about where the money flows, click here for our Capital section


To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook